The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 89BIO INC | COM | 282559103 | 463,200 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
| AADI BIOSCIENCE INC | COM | 00032Q104 | 1,210,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 1,667,200 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
| ACELYRIN INC | COM | 00445A100 | 2,034,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| ACELYRIN INC | COM | 00445A100 | 2,034,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | ||
| ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 622,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 2,730,243 | 201,197 | SH | SOLE | 201,197 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 5,816,700 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 12,645,000 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 7,604,311 | 664,132 | SH | SOLE | 664,132 | 0 | 0 | |||
| AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 6,037,500 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | |||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 2,128,000 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 3,936,650 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 2,472,600 | 65,000 | SH | Call | SOLE | 65,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,564,800 | 120,000 | SH | Call | SOLE | 120,000 | 0 | 0 | ||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 1,346,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
| ARGENX SE | SPONSORED ADR | 04016X101 | 1,229,075 | 2,500 | SH | SOLE | 2,500 | 0 | 0 | |||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 7,959,400 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 2,238,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 414,700 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 7,687,900 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
| BIOMEA FUSION INC | COM | 09077A106 | 894,400 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 1,977,750 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 6,337,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 3,016,915 | 101,443 | SH | SOLE | 101,443 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 3,547,089 | 237,900 | SH | Call | SOLE | 237,900 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 2,651,400 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 4,134,000 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | |||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,596,750 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | |||
| FUSION PHARMACEUTICALS INC | COM | 36118A100 | 632,546 | 243,287 | SH | SOLE | 243,287 | 0 | 0 | |||
| IMMUNOGEN INC | COM | 45253H101 | 2,777,250 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 4,990,700 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 3,263,150 | 85,000 | SH | Put | SOLE | 85,000 | 0 | 0 | ||
| INHIBRX INC | COM | 45720L107 | 642,250 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 963,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 2,113,625 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | |||
| KRYSTAL BIOTECH INC | COM | 501147102 | 9,280,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 1,511,325 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | |||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 8,397,300 | 57,500 | SH | SOLE | 57,500 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 77,788 | 61,250 | SH | SOLE | 61,250 | 0 | 0 | |||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 2,613,600 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | |||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 18,810,000 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | |||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 14,250,000 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | ||
| MORPHOSYS AG | SPONSORED ADS | 617760202 | 2,688,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 4,096,150 | 395,000 | SH | SOLE | 395,000 | 0 | 0 | |||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 4,334,109 | 705,881 | SH | SOLE | 705,881 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 6,672,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| RAIN ONCOLOGY INC | COM | 75082Q105 | 280,085 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | |||
| REPLIMUNE GROUP INC | COM | 76029N106 | 4,277,500 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
| REVANCE THERAPEUTICS INC | COM | 761330109 | 4,014,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 6,044,550 | 295,000 | SH | Call | SOLE | 295,000 | 0 | 0 | ||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 747,520 | 64,000 | SH | SOLE | 64,000 | 0 | 0 | |||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 4,848,800 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 18,183,000 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | ||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 21,906,000 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | ||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 2,773,100 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | |||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 2,904,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 4,356,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | ||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 7,108,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 4,187,000 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | |||
| TG THERAPEUTICS INC | COM | 88322Q108 | 8,360,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 1,341,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| UNIQURE NV | SHS | N90064101 | 1,442,650 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 7,137,200 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 1,215,550 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 733,500 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | |||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 2,490,750 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 4,218,500 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,380,166 | 98,951 | SH | SOLE | 98,951 | 0 | 0 | |||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 2,006,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||